Marquant Partners is a full service transaction and strategic advisory firm. We have expertise in every step of the transaction process from strategic planning to project mobilization, counterparty identification and stratification, diligence, negotiation, deal closure and associated IR-PR activities. Transactions require a team approach, and depending upon the specific client requirements, we provide a range of services from providing a team to run the entire deal process, through to providing specific point expert services.

Typical transactions include inward and outward licensing, mergers, acquisitions, divestments, joint ventures and alliances. Our team is also experienced in IPOs in USA, Europe and Japan.

Collectively Marquant's Partners have close to a hundred years of experience in the pharma and biotechnology sectors, and a deep relationship base. Our experience touches the entire value chain, from successful in and out licensing, mergers, acquisitions, joint ventures, alliances, company formation, financing and fund raising activities, through effective portfolio planning and management, and to developing and implementing successful drug registration strategies.

Working discretely with our clients to assess their strategic alternatives on an ongoing basis to maximize value creation,
and planning successful exit strategies are core to our general advisory and valuation capabilities. Our services are focused on creating value and forging long term relationships with our clients as they advance.